Sitagliptin and oral cancer risk in type 2 diabetes patients.
about
Sitagliptin and oral cancer risk in type 2 diabetes patients.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Sitagliptin and oral cancer risk in type 2 diabetes patients.
@en
Sitagliptin and oral cancer risk in type 2 diabetes patients.
@nl
type
label
Sitagliptin and oral cancer risk in type 2 diabetes patients.
@en
Sitagliptin and oral cancer risk in type 2 diabetes patients.
@nl
prefLabel
Sitagliptin and oral cancer risk in type 2 diabetes patients.
@en
Sitagliptin and oral cancer risk in type 2 diabetes patients.
@nl
P2860
P356
P1433
P1476
Sitagliptin and oral cancer risk in type 2 diabetes patients.
@en
P2093
Chin-Hsiao Tseng
P2860
P304
96753-96760
P356
10.18632/ONCOTARGET.18239
P407
P577
2017-05-27T00:00:00Z